PROCEPT BioRobot Rg
PRCT
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
06/18/2026 - 02:00:00
Bid
06/18/2026 - 10:17:13
Bid
Volume
Ask
06/18/2026 - 10:17:13
Ask
Volume
20.91
-1.19 ( -5.38% )
20.92
100
21.19
100
More information
Analysis by TheScreener
16.06.2026
Evaluation Slightly negative  
Interest None  
Sensibility High  
Analysis date: 16.06.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 12.05.2026.
Interest
  None
No stars since 12.06.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 21.04.2026 at a price of 24.76.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Negative
 
The dividend-adjusted forty day technical trend is negative since 12.06.2026.
4wk Rel Perf
  -16.78%
 
The four-week dividend-adjusted underperformance versus SP500 is 16.78%.
Sensibility
  High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 0.99%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 5.59%.
Mkt Cap in $bn
  1.32
With a market capitalization <$2bn, PROCEPT BIOROBOTICS CORP. is considered a small-cap stock.
G/PE Ratio
  0.19
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  -37.89
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  7.08%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  11
Over the last seven weeks, an average of 11 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  30
For 1% of index variation, the stock varies on average by 0.30%.
Correlation
  0.09
Stock movements are totally independent of index variations.
Value at Risk
  7
The value at risk is estimated at USD 7.00. The risk is therefore 31.65%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  15.07.2025